UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2220
https://www.valueinhealthjournal.com/article/S1098-3015(16)33586-0/fulltext
Title :
UK Cost-Effectiveness Analysis for Management of CMV Disease in Patients Post Allogeneic Stem Cell Transplantation with a Novel Adoptive T Cell Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33586-0&doi=10.1016/j.jval.2016.09.2220
First page :
A734
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2102